Thread by @lissabauer

Starting day 2 #AACE2022 with @ArchanaSadhu talking to us about #diabetes technologies in 2022 #endotwitter

Look how far we have come in #diabetes technology and there is still a lot more to go #AACE2022. #CGM technology has been a game changer and the accuracy continues to improve with each generation

So what's new in the pipeline for #diabetes technology? Let me tell you starting with #dexcom G7. It will be smaller with a better MARD, better warm up and ALL-IN-ONE applicator and transmitter! Just pending FDA review #AACE2022 #endotwitter #medtwitter

#FreeStyleLibre 2 is already out with better MARD, and q1minute sensor readings. Libre 2 going through FDA review will be much smaller (size of a penny!)

#Eversense recently approved for 6 months of implantable use. Best MARD so far of the cgms. ONly one calibration daily is needed. On body alerts

Tandem w/ recent FDA clearance for remote bolusing. This will be a game changer for pediatric population and parents managing them, right @askewed? I'm excited about the tubeless pump in the pipeline by tandem

#Omnipod 5 is out with it's hybrid closed loop system with adjustable targets. It's still a limited release but those on the interest list can upgrade through their podder account.

#Medtronic 780G already available in Europe and soon to come to US. No more calibrations outside of the first day. Two targets and extended infusion set approved! Awaiting FDA approval

#ILet In the pipeline and undergoing clinical trials -- a fully automatic bionic pancreas -- insulin with glucagon. This will be a game changer for those who live with #diabetes. I can't wait

There are many options for #diabetes technology. Choose which one is right for your patient based on the different features. Here are some comparison charts to help you decide. Thanks @ArchanaSadhu for the great slides!

Got to catch up with @ArchanaSadhu after her amazing lecture on #diabetes technology. Great way to start day 2 of #AACE2022 #womenleaders #Endotwitter